Can Hydrogen Therapy Mitigate Cardiovascular Diseases and Support The 8 Essentials of Cardiovascular Health (CVH), of the American Heart Association
Singh RB, Tarnava A, Slezak J, Kura B, Ucarer E, Bharti M, Alhusheme S, Smail MM · 2026
Research-use notice
Independent study record
Each H2HUBB study page organizes source-linked research details for educational use. Interpretation should remain proportional to the study design, population, controls, and limitations.
H2HUBB TAKEAWAY
In a randomized controlled trial involving 60 patients with metabolic syndrome, hydrogen-rich water (HRW) significantly reduced body mass index (BMI), blood lipids, glucose, and HbA1c, and improved inflammatory and redox biomarkers compared to placebo. These findings add human evidence supporting molecular hydrogen's therapeutic potential for metabolic syndrome.
What the Findings Mean
H2HUBB reviewed how hydrogen-rich water affected the outcomes measured in 60 patients with metabolic syndrome. In a randomized controlled trial involving 60 patients with metabolic syndrome, hydrogen-rich water (HRW) significantly reduced body mass index (BMI), blood lipids, glucose, and HbA1c, and improved inflammatory and redox biomarkers compared to placebo.
What the Researchers Studied
The researchers studied 60 patients with metabolic syndrome. The study used a randomized, placebo-controlled human clinical trial. The comparison condition was placebo.
What Effects Did Molecular Hydrogen Have?
In a randomized controlled trial involving 60 patients with metabolic syndrome, hydrogen-rich water (HRW) significantly reduced body mass index (BMI), blood lipids, glucose, and HbA1c, and improved inflammatory and redox biomarkers compared to placebo. The authors concluded that additional studies suggest that H₂ can lower blood pressure and its variability, enhance physical performance, and favorably modulate gut microbiota, including increased production of short-chain fatty acids. Hydrogen therapy, administered as H₂-rich water or H₂–O₂ inhalation, has also been associated with improved sleep quality, potentially through attenuation of oxidative stress and psychological distress.
Why These Findings Matter
These findings add human evidence supporting molecular hydrogen's therapeutic potential for metabolic syndrome and contribute to the growing body of molecular-hydrogen research.
How Strong Is This Evidence?
This is human clinical evidence from a randomized, placebo-controlled human clinical trial. H2HUBB interprets the findings in the context of the study design, sample, comparator, and measured outcomes rather than using one publication as a verdict on hydrogen therapy.
Technical Study Details
H2HUBB classifies this publication as human clinical study with human clinical evidence. The research population or model was 60 patients with metabolic syndrome. The reported sample size was 60. The study used a randomized, placebo-controlled human clinical trial. The hydrogen delivery method was hydrogen-rich water.
Limitations and Safety
No separate limitations or safety findings were identified in the current-study source text available to H2HUBB.
Original Study and H2HUBB Research Context
H2HUBB presents this source-grounded research record as one contribution to the broader molecular-hydrogen evidence base. The original scholarly source is available at https://europepmc.org/article/PPR/PPR1281960.